Progress in Methodologies for Evaluating Bioequivalence of Topical Formulations
- 1 January 2001
- journal article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 2 (5) , 275-280
- https://doi.org/10.2165/00128071-200102050-00001
Abstract
Assessment of bioequivalence of topical dermatological formulations is a challenge. Currently, comparative clinical studies are used to establish bioequivalence for most formulations (except...Keywords
This publication has 11 references indexed in Scilit:
- Normalization of Stratum Corneum Barrier Function and Transepidermal Water Loss In VivoPharmaceutical Research, 2000
- Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modelingClinical Pharmacology & Therapeutics, 1999
- Bioavailability of Clobetasol Propionate – Quantification of Drug Concentrationsin the Stratum Corneum by Dermatopharmacokinetics UsingTape StrippingSkin Pharmacology and Physiology, 1999
- Assessment of Value and Applications of In Vitro Testing of Topical Dermatological Drug ProductsPharmaceutical Research, 1999
- Evaluation of the Test System Used for In Vitro Release of Drugs for Topical Dermatological Drug ProductsPharmaceutical Development and Technology, 1999
- Bioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of BioequivalencePharmaceutical Research, 1998
- Topical 0.050% Betamethasone DipropionateArchives of Dermatology, 1994
- Variability and correlation of chromameter and tape-stripping methods with the visual skin blanching assay in the quantitative assessment of topical 0.05% betamethasone dipropionate bioavailability in humansInternational Journal of Pharmaceutics, 1992
- Correlation between the drug penetration and the blanching effect of topically applied hydrocortisone creams in human beingsPublished by Elsevier ,1990
- Are Generic Formulations Equivalent to Trade Name Topical Glucocorticoids?Archives of Dermatology, 1987